Second Acquisition Deal in Pharmaceutical Industry

Second Acquisition Deal in Pharmaceutical Industry
Mazin Darwaza, Chairman of HIKMA Pharmaceutical MENA with Wael Abdin

Sudanese Commercial Law Office (SCLO) has successfully completed an assets acquisition transaction worth Ms USD.

The target was one of the largest pharmaceutical factories in Sudan “ELLIE PHARMACEUTICALS”, SCLO was rep-resenting Savanna Pharmaceuticals Co.Ltd a sub-sidiary of Hikma Pharmaceuticals PLC (London Stoke Exchange [LSE] listed company )

SCLO’s involvement in this transaction included the following:

  • Forming a Sudanese private limited liability company (the buyer) which is wholly owned by foreign companies.
  • Render many legal opinions regarding some aspects of the Sudanese investment law
  • Carry out a full legal due diligence-advice on registration of foreign capital in Sudan’s central bank-advice on intellectual property in Sudan
  • Advise on corporate finance structure
  • Negotiate on behalf of the buyer the terms of the SPA
  • Transfer all the trade marks to the buyer.
  • Advise on the regulatory issues relevant to the Pharmaceutical industry in Sudan


  • المكتب السوداني للقانون التجاري (SCLO) - الخرطوم - المنشية - مربع 25 - مبنى 2 - شقة 1
  • 00249-153-999935
  • 00249-911-446499
  • عنوان البريد الإلكتروني هذا محمي من روبوتات السبام. يجب عليك تفعيل الجافاسكربت لرؤيته.
We use cookies to improve our website. By continuing to use this website, you are giving consent to cookies being used. Cookie policy. I accept cookies from this site. Agree